An unequalled expertise in the aseptic processing and a well-known ability to answer customers’ needs made Steriline the perfect ally for pharmaceutical companies: Pierre Fabre case history
Steriline, a highly specialized manufacturer of complete lines for the aseptic injectable products processing, will attend the 2018 edition of CPhI Worldwide, the world's leading business platform for pharmaceutical professionals, being held this year in Madrid (Spain) from 9 to 11 October.
Steriline will be pleased to welcome visitors at the trade fair (Hall 4, Booth N° 4D51) offering them a comprehensive overview of its solutions.
The exhibition this year will also be an occasion to celebrate Steriline’s two-decades of collaboration with Pierre Fabre, the 2nd French private pharmaceutical Group and the 2nd dermo-cosmetics laboratory worldwide. A strong partnership that points out Steriline’s aptitude to always satisfy clients answering to their needs with tailor-made solutions.
Pierre Fabre counts subsidiaries and offices in 47 countries and distributes its products in over 130 countries. Among industrial fields in which the Group’s skill and expertise gained global recognition, it produces drugs in the form of injectable solutions for the treatment of cancer, such as the cytotoxic and biotechnological anti-cancer products manufactured in Pau factory (South-Western France), specialized in the aseptic filling under isolators.
In this compelling context, Steriline started to work with Pierre Fabre as a partner for the design, development and provision of equipment solutions for its aseptic vial filling lines, including washing machines, depyrogenation tunnels, external decontaminating machines and isolators.
In 2016 in particular Pierre Fabre had the necessity to process a new format in one of its aseptic filling lines. Through an open dialogue and its ongoing guidance to the client, Steriline advised Pierre Fabre about the opportunity to consider the implementation of a new rotary washing machine, building on the experience with a similar model by Steriline that Pierre Fabre had installed more recently within a different aseptic processing line. A dedicated project manager was assigned by Steriline to work close to Pierre Fabre’s team and identify the best solution, while assessing possible improvements and customizations to be reflected in the design of the new rotary washing machine that would replace the existing one.
Before an additional format introduction was needed, Steriline’s interfacing linear washing machine and sterilization tunnel shared the same switchboard and HMI control panel. Having to replace the washing machine with a new advanced model would have meant to suspend the production for several months (on average at least 3 times more than what happened in reality) in order to have time also to update the electric and HMI panels and make a complete revalidation of tunnel and software.
The solution proposed by Steriline focused on the importance to make one machine independent from the other, so as to keep the aseptic vial filling line running until the final installation of the new rotary washer. Therefore, Steriline engineers developed a new additional switchboard to autonomously supply only the washing machine (so allowing the sterilization tunnel to work on its own through the old electric panel) and embedded a dedicated software to control the new washer into the existing HMI panel. Moreover, the sterilization tunnel was modified at its entry side in order to facilitate the assembly and interaction with the novel washing machine.
«Steriline high specialization, know-how and experience in the aseptic processing market, coupled with their strong innovative attitude in project management – commented Hervé Santelli, Project Manager at Pierre Fabre – allowed us to achieve our goals in due time, with a solution that brought benefits to the efficiency of the whole vial filling line».
This kind of interventions planned and managed by Steriline allowed to maintain the existing system unmodified as much as possible, thus granting significant time saving in the development, test...
(All Rights Reserved)